Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 78,477Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5NOVARTIS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DABRAFENIB MESYLATE

Brand Name : TAFINLAR

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 50MG BASE

Approval Date : 2013-05-29

Application Number : 202806

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DABRAFENIB MESYLATE

Brand Name : TAFINLAR

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 75MG BASE

Approval Date : 2013-05-29

Application Number : 202806

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DABRAFENIB MESYLATE

Brand Name : TAFINLAR

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : EQ 10MG BASE

Approval Date : 2023-03-16

Application Number : 217514

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DABRAFENIB MESYLATE

Brand Name : TAFINLAR

Dosage Form : CAPSULE;ORAL

Dosage Strength : 75MG

Approval Date :

Application Number : 217514

RX/OTC/DISCN :

RLD :

TE Code :

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DABRAFENIB MESYLATE

Brand Name : TAFINLAR

Dosage Form : TABLET; ORAL SUSPENSION

Dosage Strength : 10MG

Approval Date :

Application Number : 217514

RX/OTC/DISCN :

RLD :

TE Code :

blank